Follow Important Email Alerts on Stocks like KURA from SpeculatingStocks.com. Sign up for our Email Newsletter.
KURA 'Buy' / 'Sell' Stats
Sentiment Over the Last:
10-Mins: B:0 S:0
1-Hour: B:0 S:0
6-Hours: B:0 S:0
1-Day: B:0 S:0
3-Days: B:0 S:0
1-Week: B:0 S:0
and more... sign up .
More KURA Social Data
Top Stories Today 3m
Followers: 1
'Buys' : 0
'Sells' : 0
'Buys' 7 AM :
0
'Sells' 7 AM :
0
Kura Oncology ($KURA)
$KURA (Kura Oncology)
has significant institutional ownership of at least 20% with institutional ownership of 52.5%.
$KURA Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergence of Resistance to Osimertinib in Non-Small Cell Lung Cancer.
$KURA (Kura Oncology)
has significant institutional ownership of at least 20% with institutional ownership of 50.14%.
$KURA Kura Oncology received FDA authorization to proceed with KOMET-001 Phase 1b study of KO-539.
$KURA Kura Oncology received FDA authorization to proceed with KOMET-001 Phase 1b study of KO-539.
Go to Reactions Related to KURA!
Your reaction and other reactions to $KURA pulses will show here! Post a reaction by clicking the "React Anonymously " link in any of the pulse posts in the stream above. No account required. Want to react with an account? Get a Free Account .
KURA Sentiment Today (Since 7 AM ET)
Be the Next Pulse User to Follow, 'Buy', or 'Sell' KURA .
Copy the Widget Code for KURA
The Revolution in Speculation Continues...
25,668 symbol pages... 1315
users... 3,250,494 pulses... not one
unhappy user. Sign up now, free!
Newest SpeculatingStocks Pulse User jackfitt
Headlines for Kura Oncology (KURA)
--GRAND CANYON PREBID -->
-GRAND CANYON PREBID -->
--GRAND CANYON PREBID -->
-GRAND CANYON PREBID -->
--GRAND CANYON PREBID -->
-GRAND CANYON PREBID -->
--GRAND CANYON PREBID -->
-GRAND CANYON PREBID -->
--GRAND CANYON PREBID -->
-GRAND CANYON PREBID -->